Huge choice of hot subjects including:
• Discover the vast new choice of
innovative tools for clinical trial
success
• Find out innovative ways to
fast forward projects from candidate drug to
marketed product
• Learn how to respond
innovatively to the future European competition,
regulation and economic environment to
maintain a competitive edge
• Explore the
potential of innovative designs to increase chance of
success
• Evaluate the pros and cons of
outsourcing for smarter executive
decisions
• Understand how to optimise the
clinical trial team’s in-house resources for
greater efficiency
Find out the full conference
agenda, please download the 8-page brochure >>>>>
A taste of 4 of the 25
presentations this year:
(for the full brochure please
fill out the form to the right)
Clinical trials: ‘an
Industrial Challenge’?
• Explore how to respond to change in the
regulatory environments so you are equipped
• Find out innovative ways to fast forward
projects from candidate drug to marketed
product
• Evaluate the pros and cons of
outsourcing for smarter executive
decisions
• Consider how to respond to the
future: an AstraZeneca perspective
Nanna Keeling, Clinical Information Director, AstraZeneca
Innovation with Adaptive
Clinical Trails: Perspectives from the Early Stage
• Learn about adaptations in early stage
trials, both past and present for future
success
• Explore the potential and pitfalls
of adaptive clinical trials to increase chance of
success
• Find out more about adaptive
designs and analysis, from statistical inference to how to use it to
make better decisions
Kit Roes, VP , Schering Plough
IMP or non-IMP? Key
recommendations from a Pfizer survey
• Discover the impact of
Investigational Medicinal Products in a clinical trial on labelling
and reimbursement
• Understand the EU
guidance document about IMP and non-IMP (April 2007)
• Find out the results of the EU Pfizer
survey on the impact of this guidance on labelling and reimbursement
• Consider the consequences and subsequent
recommendations for more successful trial design
Claus Goebel, Director Clinical Research, Pfizer
The 4 Keys to Successful
Clinical Trial Management
• Explore the importance of the start-up
phase for overall success
• Learn how to
better optimise the clinical trial team’s in-house and on-site
resources for greater efficiency
• Discover
the secrets for a successful medical ethical review
process
• Find out how to respond better to
the European competition to maintain a competitive
edge
Eric Hoedemaker, Medical Director, sanofi-aventis
And many more - to get the full
conference agenda just fill out the form to the right and
we'll send you the 8-page brochure >>>>>
